International Conference on Medicinal Chemistry and Pharmacokinetics
ICMCPK
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track focuses on the latest breakthroughs in medicinal chemistry, emphasizing novel synthetic methods and their applications in drug development. Researchers are invited to present their findings on innovative compounds and their therapeutic potentials.
SDG 3
SDG 4
This session will explore pharmacokinetic modeling and ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) studies that are crucial for drug efficacy and safety. Contributions that highlight new methodologies and case studies are particularly encouraged.
SDG 3
SDG 9
This track will delve into the role of molecular modeling techniques in the drug discovery process, including structure-based drug design and virtual screening. Presentations should focus on computational approaches that enhance the understanding of drug-target interactions.
SDG 3
SDG 9
This session aims to bridge the gap between chemistry and biology, showcasing how chemical tools can facilitate therapeutic innovations. Researchers are invited to discuss their work on small molecules, biologics, and their implications in treating diseases.
SDG 3
SDG 9
This track emphasizes the importance of translational research in bridging laboratory discoveries with clinical applications. Presentations should highlight successful case studies where medicinal chemistry has led to new therapeutic strategies.
SDG 3
SDG 4
This session will cover cutting-edge laboratory techniques that are pivotal in the drug development pipeline, from synthesis to testing. Contributions that introduce novel methodologies or improve existing techniques are highly encouraged.
SDG 3
SDG 9
This track will focus on innovative synthetic methodologies that enhance the efficiency and effectiveness of drug synthesis. Researchers are invited to share their insights into new reactions, catalysts, and synthetic pathways.
SDG 3
SDG 4
This session will explore emerging trends and technologies in pharmacokinetics, including novel analytical techniques and modeling approaches. Participants are encouraged to discuss how these advancements can impact drug development and patient care.
SDG 3
SDG 9
This track will highlight integrative approaches that combine medicinal chemistry with other disciplines such as genomics and proteomics. Presentations should focus on collaborative efforts that enhance drug discovery processes.
SDG 3
SDG 4
This session will focus on identifying and validating therapeutic targets for drug design, emphasizing the role of medicinal chemistry in this process. Researchers are invited to present their work on target identification and the design of lead compounds.
SDG 3
SDG 4
This track will address the current challenges faced in the field of medicinal chemistry and discuss future directions for research and development. Participants are encouraged to propose innovative solutions and strategies to overcome these challenges.
SDG 3
SDG 4